Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
- Written by Lynne Chepulis, Associate Professor, Health Sciences, University of Waikato
Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.
The decision comes after years of advocacy from patient groups and clinicians.
But there are problems within the broader system –...





